Horizon 2020 - Education.gouv.frcache.media.education.gouv.fr/file/2013/76/3/... · Horizon 2020 -...
Transcript of Horizon 2020 - Education.gouv.frcache.media.education.gouv.fr/file/2013/76/3/... · Horizon 2020 -...
Défi sociétal 'Santé, démographie, bien-être' + les futurs appels
Horizon 2020
Dr Ruxandra Draghia Akli, MD, PhD DG Recherche & Innovation
Commission européenne
Réunion d’information et de mobilisation Défi sociétal 'Santé, démographie, bien-être', Horizon 2020
Paris, 28 novembre 2013
Disclaimer
Pending formal adoption by the EU of the Horizon 2020 legal texts, the content of these slides is not definitive and so should not be taken as such, nor used or referred to as such in any way or for any purpose
Building on the FP7
experience…
• …for collaborative research, global consortia, and public-private co-operation
• …to fund excellent applied health and ageing research and innovation
• …to bring together leading players from Europe and across the globe
• …to tackle key European and global health challenges
FP7 'Health' – the largest multi-national fund…
Building on experience
France – FP7 top performer in Europe
FP7 funding received by country
The French FP7 involvement in figures
578 projects
309 French organisations involved
1122 participations
€828 million total cost
€604 million EU funding
€538,000 EU funding for each participation (average)
Connections with EU Member States
& FP7 Associated countries
Horizon 2020
'Health, demographic
change and wellbeing'
What is Horizon 2020?
− Responding to the economic crisis to invest in future jobs and growth
− Addressing people’s concerns about their livelihoods, safety and environment
− Strengthening the EU’s global position in research, innovation and technology
http://ec.europa.eu/research/horizon2020
The EU’s 2014-20 programme
for research & innovation
A core part of Europe 2020,
Innovation Union &
European Research Area
Horizon 2020 - what's new?
• A single programme bringing together three separate programmes/initiatives*
• Coupling research to innovation – from research to retail, all forms of innovation
• Focus on societal challenges facing European society e.g. health and ageing, clean energy and transport
• Simplified access, for all companies, universities, institutes in all EU countries and beyond
The 7th Research Framework Programme (FP7), innovation aspects of Competitiveness and Innovation Framework Programme (CIP), EU contribution to the European Institute of Innovation and Technology (EIT)
Three priorities
Excellent science
Industrial leadership
Societal challenges
European Research Council (ERC)
Frontier research by the best individual teams
13 095
Future and Emerging Technologies
Collaborative research to open new fields of innovation
2 696
Marie Skłodowska-Curie actions (MSCA)
Opportunities for training and career development
6 162
Research infrastructures (including e-infrastructure)
Ensuring access to world-class facilities
2 488
Proposed funding (million EUR, 2014-2020)*
All funding figures in this presentation are subject to the pending Multiannual Financial Framework Regulation by the EP and the Council
Proposed funding (million EUR, 2014-2020)*
All funding figures in this presentation are subject to the pending Multiannual Financial Framework Regulation by the EP and the Council
Leadership in enabling and industrial technologies (LEITs)
(ICT, nanotechnologies, materials, biotechnology, manufacturing, space)
13 557
Access to risk finance
Leveraging private finance and venture capital for research and innovation
2 842
Innovation in SMEs
Fostering all forms of innovation in all types of SMEs
616 + complemented by
expected 20% of budget of societal challenges + LEITs
and
'Access to risk finance' with strong SME focus
Proposed funding (million EUR, 2014-2020)*
All funding figures in this presentation are subject to the pending Multiannual Financial Framework Regulation by the EP and the Council
Health, demographic change and wellbeing 7 472
Food security, sustainable agriculture and forestry, marine and maritime and inland water research and the bio-economy
3 851
Secure, clean and efficient energy * 5 931
Smart, green and integrated transport 6 339
Climate action, environment, resource efficiency and raw materials
3 081
Inclusive, innovative and reflective societies 1 310
Secure societies 1 695
Science with and for society 462
Spreading excellence and widening participation 816
Strategic Initiatives
Innovative Medicines Initiative 2 www.imi.europa.eu
European & Developing Countries Clinical Trials Partnership (EDCTP2)
www.edctp.org
Active and Assisted Living 2 www.aal-europe.eu
European Innovation Partnership on Active and Healthy Ageing https://webgate.ec.europa.eu/eipaha
• Translating science to benefit citizens
• Improve health outcomes
• Support a competitive health & care sector
• Test and demonstrate new health & care models, approaches and tools
• Promote healthy and active ageing
Horizon 2020 - Societal Challenge 1
Do also look elsewhere! EU support of health related research & innovation is not limited to Societal Challenge 1
Less prescriptive topic texts
Two-year work programme
Stronger focus on end users
Broad topics
Challenge-driven
A new approach
More opportunities for SMEs
• Some 20% of the total budget for societal challenges/LEITs to go to SMEs
• Simplification – a great benefit to SMEs
• A new SME instrument
• 'Innovation in SMEs' - a dedicated activity for research-intensive SMEs
• 'Access to risk finance' with strong SME focus (debt and equity facility)
Image courtesy of Vlado/ FreeDigitalPhotos.net
Wanted: international cooperation
• A priority
• Key goal: more and better international cooperation
• Horizon 2020 is open to participation from across the world
• Targeted actions across the entire programme
• Horizon 2020 Regulation and Rules for Participation apply
Getting you started faster
• A single set of simpler and more coherent participation rules
• New trust/control balance
• Just 2 funding rates for different beneficiaries and activities
• Single flat rate for overhead or 'indirect costs'
• Simpler financial regulation to come
• 8 months time-to-grant exceptions for the ERC and in duly justified cases
Image courtesy of ponsuwan/ FreeDigitalPhotos.net
Next steps
Starting fr
Adoption of work programme and publication of first calls for proposals
11 December 2013
Submission deadlines for your proposals
Two-stage: 11 March & 19 August
All others: 15 April
SME instrument: check Work Programme
Horizon 2020 national launch events
Until January 2014 Full list: http://ec.europa.eu/research/horizon2020
National info days Please check with your national contact points http://ec.europa.eu/research/participants/portal/page/nationalcontactpoint
Collaborative
Research
The draft Work Programme 2014/15 is online
http://ec.europa.eu/research/horizon2020 (in 'Official Documents')
Understanding the call topics: example
'PHC 2 – 2015'
'Specific challenge'
'Scope'
'Expected impact'
'Type of action'
The Work Programme 2014/15 in brief
Call for 'co-ordination activities' 16 topics (10 in 2014, 6 in 2015)
Call 'personalising health and care' 34 topics (15 in 2014, 17 in 2015, 2 open in both years)
€ 1,21 billion
• Understanding health, ageing & disease
• Effective health promotion, disease prevention, preparedness and screening
• Improving diagnosis
• Innovative treatments and technologies
• Advancing active and healthy ageing
• Integrated, sustainable, citizen-centred care
• Improving health information, data exploitation and providing an evidence base for health policies and regulation
Call 'personalising health and care' Seven focus areas
• European Innovation Partnership on Active and Healthy Ageing
• Global Alliance for Chronic Diseases (GACD) – Diabetes (2014)
• Joint Programming Initiative 'More Years, Better Life's (2014)
• Joint Programming Initiative on neurodegenerative diseases (JPND, 2014)
• Global Research Collaboration for Infectious Disease Preparedness (2014)
• European Reference Networks (2015)
Call for 'co-ordination activities' Support for European and International Initiatives
• Joint Programming Initiative on neurodegenerative diseases (JPND, 2014)
• Translational cancer research (2014)
• Systems medicine for clinical needs (2014)
• Rare diseases (2014)
• 2015: Brain-related disorders, antimicrobial resistance, cardiovascular diseases
Call for 'co-ordination activities' Completing the European Research Area
Applying for funding – the process in brief
Publication of the calls
Submission of proposals
Signature grant agreement
Information on the outcome of the evaluator
Time to prepare
the proposal
Preparation
of the grant
Evaluation
Applying for funding – your one-stop shop
http://ec.europa.eu/research/participants/portal
Learn more
http://ec.europa.eu/digital-agenda/en/life-and-work/living-healthy-ageing-well
http://ec.europa.eu/research/health
http://ec.europa.eu/research/participants/portal
http://cordis.europa.eu/home_en.html
Innovative
Medicines
Initiative 2
The biggest public/private partnership in Life Science aiming to:
• Make drug R&D processes in Europe more innovative and efficient
• Enhance Europe’s competitiveness
• Address key societal challenges
Features:
• 1:1 funding, joint decision making
• All EU funds go to SMEs, academia, patient organisations and regulatory agencies
• Large pharmaceutical industry, represented by EFPIA, contributes in-kind
33
Innovative Medicines Initiative: Europe’s fast track to better medicines
IMI state of play
€1.6 bn COMMITTED
€2 bn by end of 2013
42 PROJECTS
+ up to 15 more from calls 8-11
Call 10 application deadline 28 January 2014, 17:00:00 Brussels time Call 11 to be launched in December, indicative text on IMI website
600 Academic & research
teams
388 EFPIA teams
14 regulators
22 patient org.
113 SMEs
In the Pipeline: IMI2
• Commission proposal from 10 July, legislative process ongoing
• Mission: create an even more powerful research and innovation machine, with broader objectives and a wider range of activities and partners
• Proposed budget: €3.45 billion, equally shared between public
and private partners
• Key objectives:
• Pave the way for the breakthrough vaccines, medicines and treatments which we will need in the near future
• Enable top quality research and innovations with great public health benefits and commercial possibilities
European and
Developing
Countries Clinical
Trials Partnership 2
EDCTP – time for renewal
Commission proposal for EDCTP2:
Broader scope + neglected infectious diseases, all clinical phases, diagnostics and delivery optimisation
More EU co-funding almost €700 million
Longer duration 10 years
Timetable • July 2013
Commission adopts proposal (as part of the 'Innovation Investment Package')
• 3 Dec 2013: Competitiveness Council - approval of Council position on the package
• 9 Jan 2014 Committee vote in the European Parliament expected
• First half of 2014 Adoption and start of EDCTP2
From EDCTP1…
Disease profile: HIV/AIDS, TB, Malaria Interventions: Drugs, Vaccines , Microbicides Capacity Building in sub-Saharan Africa
Scope of activities
Disease profile: HIV/AIDS, TB, Malaria, NIDs Interventions: Drugs, Vaccines , Microbicides, Diagnostics Capacity Building in sub-Saharan Africa
…to EDCTP2 Scope of activities
EDCTP2 – annual work plan
Integrated Activities
Activities selected/funded centrally by the EDCTP secretariat Horizon 2020 rules apply with derogation
Minimum: 2 participating states + 1 African partner Participating States Initiated Activities
Selected, funded and managed by states participating in EDCTP Co-funding from the EU contribution, in some cases, Joint Activities with 3rd Parties
EDCTP and a 3rd party publish a call together
Active & Assisted
Living Joint Programme 2
Europe's population is ageing…
Necessity
Opportunity
••• 43
Dependency Ratio
From 1:4 to 1:2
80+ doubles by 2025
Cost of Care
Up by 4-8 % of GDP by 2025
Human Resources
Shrinking work force
Lacking 20 million carrers by 2020
Empowerment
Active Ageing
New Care Models
Integrated care
Large Efficiency gains
Growth and Markets
€3000 billion wealth
85 Million consumers & growing
Ambient Assisted Living
€600 million + EU funding of €150 million
22 European countries
2-3 years to market
120+ projects 40%+ SMEs
• Market-oriented ICT research in assisted living technologies & services
• Strong demand/impact orientation
• Participation according to national rules
• Active and Assisted Living JP
• New instruments e.g. prizes or innovation grants
• Participating countries pay €225 million (indicative)
• EU pays up to €175 million (indicative, ~40% of total public funding)
AAL 2 – setting sail for new horizons
• SME participation of >40%
• Demand side participation ~20%
• Leverage effect: €175 million EU €225 million MS €300 million
private sector
• >25% of projects going to market
• >50% of projects securing IPR
• Time to contract less than 9 months
AAL 2 – setting sail for new horizons
European Innovation
Partnership on
Active and Healthy Ageing
A new approach
• A wide partnership: patients, carers, financers, pharma, ICT, hospitals, ministries …
• A shared vision on ageing in Europe
• Committed to a clear target: 2 more healthy life years by 2020
• Focusing on just 6 work areas and delivery by 2015
• Commitment by "invitation to commit", with public & peer scrutiny
• No ring fenced EU funding
• Stakeholder and political leadership
A network of actions and players
• Action Groups Partners committed to work together on a specific EIP action
• (Candidate) Reference Sites 'EIP best practice' regions
• Marketplace for innovative ideas Open online platform @
1,000 regions &
municipalities
1 billion euro
committed by partners
30 mio citizens,
>2 mio patients
> 500 commitments
in six Action Groups
3,000 partners & 300
leading organisations
32 regions as Reference sites
of Innovative Practices
A critical mass of activity
Marketplace
>45,400 visits >880
registered users
Reference Sites - coverage
32 sites selected for self-
assessment and peer-
review
71 good practices of innovation-based
integrated care models
'Star' ranking = readiness for
replication and coaching
13 Reference Sites
12 Reference Sites
7 Reference Sites
Learn more
• ICT for Ageing Well http://ec.europa.eu/digital-agenda/en/life-and-work/living-healthy-ageing-well
• ICT Policy Support Programme http://ec.europa.eu/ict_psp
• Ambient Assisted Living Joint Programme www.aal-europe.eu
• JPI - More Years – Better Lives www.jp-demographic.eu
• Active and Healthy Ageing Partnership http://ec.europa.eu/active-healthy-ageing
• Contact CNECT-ICT4ageing (at) ec.europa.eu
Merci beaucoup!